Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Eastern Biotech, a Dubai Based Biotech Company, Introduces Telomere Test to the GCC Countries


News provided by

Eastern Biotech & life sciences and Life Length

08 Sep, 2016, 14:07 GMT

Share this article

Share toX

Share this article

Share toX

This image opens in the lightbox
Eastern Biotech & life sciences logo (PRNewsFoto/Eastern Biotech & life sciences)

DUBAI, UAE and MADRID, September 8, 2016 /PRNewswire/ --

Life Length, based in Madrid, Spain, the world leader in telomere testing appoints Eastern Biotech as its exclusive partner in the region to launch this state of the art diagnostic product.

     (Logo: http://photos.prnewswire.com/prnh/20160908/405564LOGO )

Are Telomeres the key to aging? Telomere Analysis Technology® has the potential to estimate true Biological age and help in early intervention of lifestyle disorders.  

Telomere length is increasingly being recognized as an independent variable in predicting disease. A study of more than 43,000 subjects reported in the British Medical Journal concluded that telomere length is an independent risk factor for cardiovascular disease. A large meta-analysis showed significant association between shortened telomere length and Type 2 diabetes. Other studies are showing that the finding of short telomeres may be associated with the aggressiveness of certain cancers.

The field of telomere biology has grown dramatically since the award of the 2009 Nobel Prize for the discovery of telomerase. Clinicians today are increasingly becoming interested in incorporating telomere testing into their practices. This is largely driven by two factors: a growing understanding of the role telomeres play in personalized medicine; and increasing consumer demand for integrative treatment that can slow the aging process.

Dr. Faruq Badiuddin, Managing Director Eastern Biotech & life sciences explains, "The development of reliable commercial testing now allows for the measurement of individual telomere lengths and quantification of the number of critically short telomeres, both key determinants in overall cellular health. Measurement of this novel biomarker holds promise for improving early disease identification, risk assessment, and treatment of lifestyle disorders such as cardiovascular disease, diabetes, and some cancers." Advance bookings for the test are underway and appointments will begin early August.

Stephen J. Matlin, Chief Executive Officer for Life Length quotes, "Perhaps the greatest value of telomere testing is in obtaining serial measurements by incorporating it as part of an annual health status assessment. It is like a report card, letting both the physician and the patient know how well the total intervention and program is working. This requires two pieces of data: 1) the number and percent of critically short telomeres and, 2) the rate of telomere attrition. Annual snapshots may also serve as powerful lifestyle behavior change motivators or as tools to enhance treatment adherence."

About Telomere Analysis Technology® (TAT®) 

Telomere Analysis Technology is a U.S.A. Federally FDA ("CLIA") Accredited proprietary diagnostic assay for assessing the level of organismal aging of an individual by measuring individual telomeres at the chromosomal level, cell-by-cell, in white blood cells. Using a special microscope, TAT measures over 100,000 individual telomeres per patient sample that are analyzed in quintuplicate replicates to ensure high levels of reproducibility and accuracy.  As it is the shortest telomeres that cause cellular senescence and not average (mean) telomere length, the TAT provides the percentage of short telomeres; those responsible for driving replicative senescence and which have been shown to be a significant contributing factor to the onset of age-related, chronic diseases.

About Eastern Biotech & life sciences  

Eastern Biotech & life sciences is a biotechnology company headquartered in Dubai, United Arab Emirates. Founded in 2005, Eastern Biotech is a pioneer in its field and has an increasing presence in the other GCC countries. The company provides highly specialized diagnostic services which include Anti-Aging & Wellness testing, Genetic Testing for Fitness & Nutrition, Nutritional & Fitness consultation, Cancer genetic testing, Genetic Counseling, DNA Ancestry, Food Intolerance & Allergy testing, and many more. Visit http://www.easternbiotech.com or http://www.telomeretest.ae for more information.

About Life Length 

Founded as a spin-off of the Spanish National Cancer Research Center, Life Length offers a number of proprietary tests for measuring cellular senescence, a crucial biomarker for establishing biological age, for early detection of chronic diseases and for risk stratification. Life Length is the only company in the world able to measure telomeres individually at the chromosomal level with its Telomere Analysis Technology® (TAT®). Life Length provides its testing services to the pharmaceutical and related industries for drug and product R&D and clinical studies, as well as to physicians working in preventive and personalized medicine for patient care together with such fields as cardiology and oncology in which telomeres have been shown to play a significant contributing in disease development. Life Length is accredited by the U.S. Department of Health as a clinical laboratory under the CLIA legislation and also IS0 15189 certified. For more information go to http://www.lifelength.com.

Press Contact:

Ranjini Mohan
Product Manager
Eastern Biotech & life sciences
Email: ranjini.mohan@easternbiotech.com
+971(0)4-450-3875

Yessica Fernandez-Cruz
Sales & Marketing Manager
Life Length
Email: yfernandez@lifelength.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.